Meta AnalysisID 7008
灵芝对人体代谢谱的有益作用：随机对照试验的系统评价与Meta分析
CRD42023473544
Does Ganoderma Lucidum supplementation have beneficial effects on metabolic profiles?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Herb: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 7008
- Evidence Id
- 15566
- Core Evidence Id
- 15566
- Source Meta Analysis Id
- 6994
- Herb2 Meta Analysis Id
- HBMA006994
- Crd Id
- CRD42023473544
- Title
- Beneficial Effects of Ganoderma Lucidum on Metabolic Profiles among Human Studies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCT)
- Review Question
- Does Ganoderma Lucidum supplementation have beneficial effects on metabolic profiles?
- Study Type Included
- Articles are designed as interventional studies, either RCTs, non-RCTs, quasi-experimental studies, or multiple arm studies.
- Condition Being Studied
- Internal Medicine, Endocrine, Complementary and Alternative Medicine
- Participant
- Inclusion criteria for participants: - Human studies that assessed the effects of G.lucidum on metabolic profiles (lipid and glycemic parameters) Exclusion criteria for participants: - taking medications that may interact with G. lucidum (such as warfarin or aspirin) or subjects with any disease interfering with weight loss - the use of any weight-loss or fat-blocking drugs - Known mushroom allergy - Pregnancy and breastfeeding - being on immunosuppressants - diagnosed mental illness
- Animal
- Human Disease Modelled
- Intervention
- All participants in the intervention groups received oral G.lucidum
- Comparator Control
- Participants were given placebo
- Main Outcome
- Outcomes of interest in this study are the differences of lipid profiles (total cholesterol, LDL, triglycerides, HDL) and glycemic profiles (fasting plasma glucose) between the G.lucidum and the placebo group. Measures of effect Lipid profiles (total cholesterol, LDL, triglycerides, HDL), fasting plasma glucose (FPG) for patients in the G.lucidum group and placebo group are going to be measured and reported as numerical (continuous) data. The data will be presented in mean ± standard deviation for normally distributed data or median (interquartile range) for non-normally distributed data. The p-value will also be included for each item to show if the results are significant.
- Outcome Measure
- Additional Outcome
- anthropometric (BMI, weight), blood pressure, liver functions, antioxidant parameters Measures of effect These outcomes are not going to computed in the meta-analysis and only undergo qualitative synthesis.
- Study Method
- Intervention, Meta-analysis, Systematic review
- Keyword
- MeSH headings have not been applied to this record
- Contact
- Steven Alvianto [email protected]
- Organisational Affiliation
- Faculty of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia
- Funding Source
- This study did not receive any specific grant nor funding from any agencies or sponsors.
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- Indonesia
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-10-23
- Registration Date
- 2023-11-03
- Anticipated Start Date
- 2023-10-23
- Anticipated Completion Date
- 2024-04-30
- Title Cn
- 灵芝对人体代谢谱的有益作用：随机对照试验的系统评价与Meta分析
- Title En
- Beneficial Effects of Ganoderma Lucidum on Metabolic Profiles among Human Studies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCT)
- Bilingual Status
- complete